Topical Therapies for Treatment of Cervical Intraepithelial Neoplasia 2-3

NIH RePORTER · NIH · N01 · $225,296 · view on reporter.nih.gov ↗

Abstract

Develop and conduct a phase 1 clinical trial to assess the safety and acceptability of once-weekly self-administered intravaginal application of 5-flurouracil (5-FU) and imiquimod used on alternating weeks for up to 16 weeks in women aged 18-45 years with biopsy confirmed high-grade cervical intraepithelial lesions.

Key facts

NIH application ID: 10189431
Project number: 261201200031I-P00003-26100011-1
Recipient: UNIVERSITY OF ARIZONA
Principal Investigator: Sherry Chow
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $225,296
Award type: —
Project period: 2017-09-15 → 2022-07-31